Live feed
Filing
SC 13G/A
SC 13G/A0000902219-24-000044·Apellis Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Apellis Pharmaceuticals Inc
Security class unavailable · CUSIP: 03753U106
Event date: 2023-12-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 16,477,850
- Percent of class
- 13.9100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-24-000044
- Form type
- SC 13G/A
- Filer
- Apellis Pharmaceuticals, Inc.
- CIK
- CIK 1492422
- Filed
- Feb 08, 2024
- Reporting period
- Dec 29, 2023
- Description
- Schedule 13G beneficial ownership